LifeMD, Inc.
corporate_fare Company Profile
LifeMD, Inc. (NASDAQ:LFMD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 13 items for LFMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-15, rated 8/10. Across its 13 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for LFMD spans 8-K, 10-Q, 10-K.
Recent high-impact activity:
- LifeMD Lands Exclusive AT&T Deal: Free Virtual Care for 100M+ Customers
- LifeMD Misses Q2 Revenue, Slashes 2026 Guidance on GLP-1 Shift
- LifeMD Forms Exclusive Telehealth Partnership for XYOSTED Testosterone Program
- LifeMD Lands Exclusive Deal for XYOSTED Testosterone Program, Targeting Millions of Men
- LifeMD Reports Wider Q1 Loss, Breaches Debt Covenant, Raising Liquidity Concerns
Financial Snapshot
Short Interest & Short Volume
7.52 days to coverFINRA reported short interest of 7,395,023 shares in LFMD as of the September 15, 2026 settlement, a 2.2% increase from the prior period — about 7.5 days to cover at its recent average daily volume. On October 2, 2026, 66.1% of LFMD volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for LFMD, detected from its recent SEC filings.
Significant Increase in Net Loss · Debt Covenant Breach Reported
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →